Chronic pelvic pain of unknown etiology is a common clinical condition and may develop as a result of cross-sensitization in the pelvis when pathological changes in one of the pelvic organs result in functional alterations in an adjacent structure. The aim of the current study was to compare transient receptor potential vanilloid 1 (TRPV1) activated pathways on detrusor contractility in vivo and in vitro using a rat model of pelvic organ cross-sensitization. Four groups of male Sprague-Dawley rats (N=56) were included in the study. 
INTRODUCTION

Co-morbidity of clinical conditions characterized by chronic pelvic pain (CPP) has recently
gained an extra attention from physicians and scientists. Painful bladder syndrome/Interstitial cystitis, irritable bowel syndrome, non-bacterial prostatitis/chronic pelvic pain syndrome, vulvodynia and dysmenorrhea form a group of functional disorders with CPP of unknown etiology with the rate of concurrent diagnoses reaching up to 30-40 % (2,37) . Limited understanding of the causes, underlying mechanisms and symptomatic complexity in patients with multidimensional pelvic pain make CPP disorders extremely difficult to cure. Clinical phenotyping of patients with CPP has been recently proposed in an attempt to clarify heterogeneity of these populations and to improve treatment by using individual targeted therapy for each patient (31) .
One emerging concept for the co-existence of clinical disorders with functional CPP includes cross-sensitization within the pelvis due to shared neural pathways connecting different pelvic organs (5, 10, 26) . Cross-sensitization develops as a result of noxious stimulus transmission from a diseased pelvic organ to an adjacent normal structure resulting in neurogenic inflammation and the occurrence of functional changes in previously normal pelvic structures (26) .
Several animal models have gone through the initial testing to mimic the co-morbidity of human disorders and to investigate the mechanisms of multisystemic CPP (28, 36, 38) . Previous animal studies have established a correlation between structural pathophysiological changes in the directly affected pelvic organs and secondary dysfunctions developed in adjacent pelvic structures (9, 27, 28, 36) . It has been determined that colonic inflammation causes hyperactivity of bladder afferent fibers (44) , hyperexcitability of bladder projecting sensory (27, 28) and spinal (38) neurons, increased release of pro-inflammatory neuropeptides in the urinary bladder (34, 45) , and changes in the detrusor contractility (32) . However, the exact pathways of transmission of nociceptive information from the inflamed colon to the urinary bladder as well as receptors and molecules activated during this transmission remain elusive.
Transient potential vanilloid receptor 1 (TRPV1) has been of interest in studies of pain and noxious stimulation for many years (11, 12, 13) . TRPV1 agonists are well known for causing prolonged desensitization of sensory neurons and fibers followed by extended refractory period and reduced sensitivity to subsequent noxious stimuli (4) . The ability of vanilloids to reduce pelvic pain was tested in patients with painful bladder syndrome/interstitial cystitis (15, 35) and in patients with urge incontinence associated with refractory detrusor overactivity (25, 41) .
In this study, we investigated the role of TRPV1 activated pathways on the detrusor contractility in vivo and in vitro using a rat model of pelvic organ cross-sensitization induced by acute colonic inflammation. The goals of the present investigation included: 1) determination of the effects of intracolonic TRPV1 receptor desensitization prior to the induction of colonic inflammation on the contractility of isolated detrusor muscle; 2) in vivo assessment of bladder function using cystometry in conscious animals; and 3) comparison of the effects of TRPV1 receptor activation and/or experimental colitis on the detrusor function under in vitro vs in vivo conditions.
MATERIALS AND METHODS
Animals and Experimental Groups
Sprague-Dawley male rats (N=56, Charles River Laboratories, Malvern, PA, 200-250 g) were used in this study. All protocols were approved by the University of Pennsylvania Institutional Animal Care and Use Committee and adhered to the guidelines for experimental pain in animals published by the International Association for the Study of Pain. For in vitro studies of detrusor contractility, rats (N=32) were housed two per cage with free access to food and water and maintained on a 12 hour light/dark cycle. Rats scheduled to undergo in vivo cystometry recordings (N=24) were ordered pre-catheterized (urinary bladder) from the vendor (Charles River laboratories, Malvern, PA, 200-250 g) and delivered 3 days post-surgery. These animals were kept in individual cages to avoid possible damage to catheters by their cage mates. Baseline cystometric parameters were recorded 5-7 days after the arrival of rats to the animal facility. That period was given for acclimation and relief of stress due to surgery and transportation.
For both in vitro and in vivo studies animals were divided into four experimental groups.
Control group of animals received intracolonic enema with saline. Resiniferatoxin (RTX, TRPV1 agonist) group had intracolonic administration of RTX (10 -7 M, 0.7-0.8 ml). RTX was dissolved in a mixture of 50% ethanol and 50% Tween 80 to make 10 -3 M stock solution. To achieve the final concentration of RTX (10 -7 M) for intracolonic instillation, 1 µl of RTX stock solution was diluted in 10 ml of saline (1:10,000 times). Third experimental group received 2,4,6-trinitrobenzene sulfonic acid (0.7-0.8 ml of TNBS, 12.5 mg in 50% ethanol/50% H 2 O), a chemical irritant causing inflammation in the colon. Rats in the fourth experimental group were pretreated with RTX followed by TNBS instillation 2 days later. All animals were sacrificed 3 days after the last treatment. Schematic presentation of the experimental design is shown in Fig.1 . Intracolonic administration of drugs was performed under light isoflurane (VEDCO Inc., St.Joseph, MO)
anesthesia via a flexible catheter made of polyethylene tubing (6 cm long, inside diameter 1.6 mm, outside diameter 2.1 mm) and attached to a 1 cc syringe. Rats were fasted for 24 hours before the instillation procedure.
To assess the severity of induced inflammation, the daily Disease Activity Index (DAI) was calculated as previously described (28) . Briefly, the DAI was determined by scoring changes in animal weight, occult blood positivity, gross bleeding, and stool consistency. We used three grades of weight loss (0 -no weight change; 1 -up to 10-12 % of weight loss; 2 ->20% loss), three grades of stool consistency (0-normal;1 -loose; and 2 -diarrhea), and three grades of occult blood (0 -negative; 1-occult blood-positive; and 2 -gross bleeding). Disease Activity Index was measured only in the group with TNBS treatment because DAI is a scoring system validated to grade specifically the severity of colonic inflammation. Out of 10 animals in TNBS group 8 developed inflammation in the colon with cumulative DAI of 4 and were included in the study. Our previous studies showed that animals with the DAI score of 4 and above developed distinct histological changes in the colon (thickening of the colonic wall, signs of hemorrage etc) without noticeable histological or biochemical changes in the urinary bladder in this model of colonbladder cross-sensitization (28, 34) . Since RTX treatment does not lead to the development of hemorrhage, wall thickening and/or GI bleeding, two groups treated either with RTX alone or with RTX-TNBS were not assessed using DAI. No data has been published so far to show whether double RTX-TNBS treatment causes the same severity of colonic inflammation when compared to TNBS alone, therefore, we could not select only animals which had some signs of colonic inflammation over those with no obvious signs of inflammation. All animals in both RTX and RTX-TNBS groups were included in the data analysis.
Distal colon and urinary bladder were evaluated for signs of inflammation postmortem. 0.5-0.7 cm segments of the colon and bladder were fixed in 4% paraphormaldehyde for histological studies and H&E staining, another part of each organ was snap frozen for MPO assay as previously described (34).
In vitro measurements of detrusor contractility
For in vitro recordings of detrusor contractility animals were sacrificed 3 days after the last treatment ( Fig.1) . Midline laparotomy was performed to remove the bladders and distal colon. The colon was evaluated for the signs of hemorrhage and wall thickening in all groups as described in our previous studies (28, 34) . The results of histological evaluation of the bladder and colon cross sections are presented in Fig.2 . Each bladder was divided in 2 halves longitudinally and weighed.
Full thickness strips of the bladder wall were tied to silk threads and suspended to L-shaped hooks in 15 ml organ bath chambers. was determined by increasing the length of each strip in 1. 
Cystometry Studies
Conscious rats were placed in cystometry cages ( evaluation before any treatment was administered. Second cystometric assessment was done at day 3 after the last assigned treatment for each animal in the manner described above (Fig.1 ).
After the final evaluation, the rats were euthanized by the overdose of isoflurane.
Statistical Analysis
All data are expressed as the mean ±standard error of the mean (S.E.M). The raw traces of detrusor contractility from in vitro experiments were analyzed manually and then exported into 
RESULTS
Effects of electric field stimulation (EFS) on the contractility of the detrusor muscle
after desensitization of colonic TRPV1 receptors. To assess the role of TRPV1 receptors in the development of cross-sensitization between the inflamed colon and urinary bladder, we performed a series of in vitro experiments using isolated urinary bladder strips. Isometric contractions were studied in response to EFS at 32 Hz. This frequency was chosen based on our previous studies that showed the alterations in detrusor contractility at higher frequencies (32) .
Acute colonic inflammation (TNBS group) did not lead to significant changes in detrusor contractility after EFS. However, intracolonic application of RTX caused 2-fold increase of maximal amplitude (Fig. 3A , n=16, p≤0.001 to control) and of contractile force slope (velocity of the contraction, Fig. 3B , n=16, p≤0.01). Desensitization of intracolonic TRPV1 receptors with RTX prior to the induction of experimental colitis had the same effect on the contractile response of the detrusor muscle as the one observed in the RTX group (Fig. 3) . We previously tested if TNBS could also trigger minor bladder inflammation by using myeloperoxidase assay and H&E staining (34). Analysis of the H&E stained cross sections of the urinary bladder performed in this study showed that neither RTX nor TNBS (alone or in combination) caused detectable structural changes in the urinary bladder confirming that the urinary bladder did not develop any signs of acute inflammatory reaction ( Fig.2 B and C) .
Response of the detrusor muscle to stimulation by potassium chloride. Stimulation of the detrusor muscle strips in vitro with potassium chloride (KCl) during active colonic inflammation (3 days post-TNBS enema) did not reveal any changes in comparison to the control group (Fig. 4) . There was no significant difference in the amplitude or velocity of the detrusor contractile response to KCl after intracolonic RTX either. However, the amplitude of urinary bladder contractions was significantly increased by 121% in the group with double treatment (RTX followed by TBNS, n=16, p≤0.001, Fig. 4A ). Contractile force slope was not affected by any treatment upon KCl stimulation (Fig. 4B ).
Cholinergic regulation of detrusor contractility in vitro.
To further investigate whether TRPV1 and/or colitis activated pathways involve changes in cholinergic regulation, we studied the concentration-response relationship of detrusor muscle strips upon application of cholinergic agonist carbachol (CCh). Cumulative addition of 10 -7
-10 -4 M of CCh to the bath solution resulted in concentration-dependent contractions of isolated detrusor strips in saline-treated animals (Fig. 5A,   n=16 ). Acute colonic inflammation significantly diminished the response of the detrusor muscle to stimulation with CCh whereas intracolonic RTX had the opposite effect ( Cystometric analysis of bladder function in awake unrestrained rats. To evaluate the effects of intact neural connections existing between the colon and urinary bladder on the detrusor contractility in vivo and compare them to in vitro results, we studied the bladder activity using cystometric measurements in conscious rats. Each experimental group consisted of 6 animals.
Cystometric evaluation was performed in all rats prior to any treatment and served as a baseline.
Differences in parameters were first compared to the baseline for each rat followed by further comparisons among the groups. Intracolonic saline did not change the cystometric profile in the control group of animals ( Fig. 6A shows raw recordings at baseline and Fig. 6B -3 days postsaline). However, substantial changes were observed at day 3 post-TNBS treatment ( Fig. 6C and   D ). Acute colonic inflammation reduced bladder capacity (BC) from 1.96±0.15 ml to 1.41±0.14 ml (N=6,p≤0.001, Fig. 7A ), micturition volume (MV) by 60% (N=6, p≤0.001 to control, Fig. 7A) , and increased the number of non-micturition contractions (NMC) from 3.7±0.7 to 15±2.7 during a twohour cystometric evaluation (N=6, p≤0.001, Fig. 7B ). Neither intracolonic RTX alone nor in combination with subsequent TNBS treatment caused substantial alterations of cystometric parameters. The only exception was observed in RTX/TNBS group and included a decreased value of BC (1.56±0.18 ml, N=6, p≤0.001, Fig. 7A ) when compared to the control group. Other cystometric parameters such as maximal pressure at micturition, intermicturition pressure interval, threshold pressure and basal pressure were unaltered in all experimental groups.
DISCUSSION
The results of our study revealed that desensitization of colonic TRPV1 receptors with and without subsequent colonic inflammation leads to changes in the contractility of detrusor muscle studied under in vitro and in vivo conditions. Previous results from our laboratory have established a correlation between activation of bladder projecting afferent pathways by colonic inflammation at the level of primary sensory ganglia and lumbosacral spinal cord (28, 38) . However, the role of intact nerve connections between the colon and urinary bladder and molecular mechanisms in the peripheral and central nervous systems were not specified. In this study, we compared detrusor contractility in vitro in the absence of extrinsic neural, hormonal or immunologic factors to in vivo bladder function using dynamic cystometric evaluation.
TRPV1 receptors are broadly expressed in the gastrointestinal tract and genitourinary system (3, 4, 17, 18, 29) . In humans, TRPV1 mRNA was detected in the prostate, testis, penis, bladder, and extrinsic sensory neurons innervating these organs (42) . In the urinary bladder, TRPV1 is expressed mostly in the detrusor smooth muscle, urothelium, interstitial cells within lamina propria (8, 33, 48) , and on the blood vessels in the bladder wall (19) . TRPV1 is also abundantly expressed in primary sensory neurons projecting to the pelvic viscera. In a rat, 69% of dorsal root ganglion (DRG) neurons innervating the urinary bladder express TRPV1 (24) .
Pathological conditions in the pelvis (trauma, inflammation, nerve injury etc) in most cases lead to up-regulation of TRPV1 signaling pathways (17, 43) . Thus, TRPV1 was shown to be upregulated in colonic afferent fibers of IBS patients and associated with symptom severity (1). Intraluminal application of capsaicin evoked painful sensations in the human gut due to activation of intestinal chemoreceptors (40) . Studies utilizing animal models of acute and chronic inflammation in different organs of gastrointestinal (6, 7, 20, 30, 39) and genitourinary (14,16,47) systems showed an increased excitability of DRG neurons receiving direct afferent input from the inflamed organs.
Intracolonic application of TRPV1 agonist RTX increased the contractility of the isolated detrusor in response to EFS and CCh without changes in response to KCl and cystometric parameters. It is known, that EFS causes contractions of the smooth muscle via stimulation of the release of neurotransmitters and neuropeptides from the nerve terminals coursing in the muscle layer while contractions in response to KCl occur due to direct effects on the muscle contractile
apparatus. An increased response to EFS after RTX application suggests that RTX stimulated an extra synthesis/release of neuropeptides from bladder nerve supply and also affected the cholinergic regulation of bladder smooth muscle. Our previous findings showed that intracolonic application of RTX can cause massive release of SP and CGRP from the bladder afferent terminals leading to the development of a neurogenic bladder over a period of time (34). Ustinova and colleagues determined that chronic colonic irritation sensitized urinary bladder afferents to noxious stimuli and caused mast cell infiltration in the bladder (45) . The latter effects were reversed by systemic administration of TRPV1 agonist capsaicin suggesting the involvement of TRPV1 receptors in colon-bladder cross-talk. Systemic RTX treatment was also found to have significant effects on cystometric parameters and the development of dribbling incontinence in some animals (23) . In these experiments, RTX increased the mean micturition interval, bladder capacity and voided volume, suggesting that structures involved in bladder afferent signaling were affected. However, we did not observe any effects of RTX on bladder function during cystometry in the group of animals that received intracolonic RTX. This could be due to the local application of RTX in our experiments and limited effects of intracolonic RTX on the central nervous system.
Our results from in vitro experiments on detrusor contractility after RTX are similar to other studies which tested spontaneous bladder contractions in isolated whole bladders in response to direct application of a TRPV1 agonist and observed a significantly increased amplitude of bladder contractions (21) . Additionally, like in our experiments, RTX also induced an increased response to CCh and changed a contractile pattern -increased bladder contractions were followed by a period of quiescence before generating a new contraction (22) . 
Perspectives and Significance
The results of our study provide evidence that colonic inflammation may trigger detrusor 
